Antibodies
|
 Antibodies to core-1 (Thomsen-Friedenreich antigen, CD176) |
Details |
Antibodies to blood group H type 2 (CD173)/ Lewis Y (CD174) antigens |
Details |
| Antibodies to peptide tumour markers |
Details |
| Antibodies to glycophorin A (CD235a) |
Details |
| Antibodies to cytokeratins |
Details |
| Antibodies to cell cycle-dependent antigens |
Details |
| Antibodies to serum albumins |
Details |
| Antibodies to glycodelin A and conductin |
Details |
For requests, please contact Hans Baumeister * the hybridomas are owned by NEMOD Biotherapeutics GmbH & Co. KG |
Download List of mouse monoclonal antibodies (PDF) Download Pricelist of Antibodies (PDF) More details about the antibodies: 
Antibodies to core-1 (Thomsen-Friedenreich antigen, TF, CD176) |
| Unique panel of antibodies towards TF, a highly specific tumour antigen |
| Nemod-TF1 | M, |
Gal 1-3GalNAc-(Nemod-TF1) (TF >> TF) Capable to bind single TFs, not cross-reactive with Core-2 |
| A78-G/A7 | M, |
Gal1-3GalNAc-(TF > TF), prognostic factor in colorectal and gastric carcinomas, HLDA7 approved |
| Nemod-TF2 | M, |
Gal1-3GalNAc-(TF > TF) comparable to A78-G/A7, but cross-reacting in ELISA with GlcNAc1-6[Gal1-3]GalNAc-, Core-2), cluster of 2 TFs at a distance of about 13 aa |
| A63-C/A9 | M, |
TF on glycophorin (mixed epitope in the extracellular domain, aa 34-55) |
| A68-B/A11 | M, |
Gal1-3GalNAc-(TF >>TF) |
| A68-E/E3 | G1, |
Gal1-3GalNAc1-(TF) |
| A68-E/A2 | G1, |
Gal1-3GalNAc1-(TF) |
Antibodies to blood group H type 2 (CD173)/ Lewis Y (CD174) antigens |
| H type 2 and Lewis Y are developmentally regulated antigens |
| CD173 (H type 2) | A46-B/B10 | M, |
Fuca1-2Gal1-4GlcNAc1. Partially cross-reacting with Lewis Y. HLDA7 approved |
| CD173 (H type 2) | A63-D/B12 | M, |
Similar to A46-B/B10 |
| CD173 (H type 2) | A51-B/A6 | A, |
Fuca1-2Gal1-4GlcNAc1, High affinity |
| CD174 (LewisY) | A70-C/C8 | M, |
Fuca1-2Gal1-4(Fuca1-3)GlcNAc1. Highly specific, not cross-reacting with H type 2; HLDA7 approved |
| CD174 (LewisY) | A70-A/A9 | G1, |
Cross-reacting with H type 2 and Leb |
| Globo-H | A69-A/E8 | M | Fuca1-2Gal1-3GalNAc- (H type 3/4) |
Antibodies to peptide tumour markers |
| Potent and approved antibodies to well established serum tumour markers |
| AFP (alpha-fetoprotein) |
A34-B/B5 | G2a | Epitope "a” (AFP). ISOBM TD-2 approved (cluster B) |
| AFP (alpha-fetoprotein) |
A34-B/B11 | G2a | Epitope "a” |
| AFP (alpha-fetoprotein) |
A34-A/B4 | G1 | Epitope "b” |
| AFP (alpha-fetoprotein) |
A34-A/D12 | G1 | Epitope "c”. ISOBM TD-2 approved (cluster B) |
| CEA (carcinoembryonic antigen, CD66e) | A42-B/A2 | G2b | Peptide epitope; cross-reacts with NCA antigen |
| PSA (prostate-specific antigen) |
A67-B/E3 | G1 | ISOBM TD-3 approved (cluster 5a) |
Antibodies to glycophorin A (CD235a) |
| Exceptional series of antibodies to defined epitopes 1) |
| A83-C/B12 | G1, |
extracellular domain | aGP>GP 2) |
| A88-A/F9 | G2b, |
extracellular domain | aGP>>GP |
| A88-D/C7 | G2b, |
extracellular domain | aGP>>GP |
| A88-E/H2 | G2b, |
extracellular domain | aGP>>GP |
| A63-B/C2 | M, |
extracellular domain | aGP>GP |
| A63-C/A9 | M | extracellular domain (+TF) | aGP only |
| A88-E/D1 | G1, |
cytoplasmic domain | aGP>GP |
| A88-E/D6 | G1, |
cytoplasmic domain | aGP>GP |
1) Inquire for epitope sequences 2) GP = glycophorin, aGP = asiologlycophorin
Antibodies to cytokeratins |
| Superb antibodies from the original source |
| Cytokeratin 19 (human) | A53-B/A2 G2a, (Ks 19.1) |
Specific for certain subtypes of epithelial cells; detects carcinoma cells in non-epithelial tissues (e.g. lymph nodes); differentiation marker in liver development. Epitope: aa 311-335. Part of the serum tumour marker test CYFRA 21-1; ISOBM TD-5 approved |
|
| Cytokeratins (broad range) |
A51-B/H4 G2a | Detects CK18 and other cytokeratins, epithal marker. Cross-reacts with lamin |
Antibodies to cell cycle-dependent antigens |
| Novel well suited cell cycle antibodies |
| A69-D/H7 | M, |
Detects mitotic cells in tissues or cell cultures. Phosphorylated epitope, antigen different from Ki-67 |
| A73-B/D12 | M, |
NuMA-related antigen |
Antibodies to serum albumins |
| Valuable tools for analytical purposes |
| Serum albumin (bovine) (BSA) |
G1, |
A23-A/D3 | High affinity, well suited for the detection of traces of BSA in tissue culture products or other preparations. Not cross-reacting with HSA. |
| Serum albumin (human) (HSA) |
G1 | A21-F8 | Not cross-reacting with BSA. |
Antibodies to glycodelin A (GdA, pp14) |
| Novel antibodies to an important pregnancy protein |
| A87-D/C5 | G1,G2b,M, |
Major pregnancy protein with immunosuppressive activity; marker of ovarian carcinomas |
| A87-D/F4 | G1, |
CH epitope of GdA |
| A87-B/D2 | G1, |
CH epitope of GdA |
Antibody to conductin (axin2, axil) |
| Unique antibody to a regulator protein of an important signaling pathway (wnt) |
| A92-C/G7 | G1, |
Conductin is upregulated in colon and liver cancer |